DNA methylation and cancer
M Kulis, M Esteller - Advances in genetics, 2010 - Elsevier
DNA methylation is one of the most intensely studied epigenetic modifications in mammals.
In normal cells, it assures the proper regulation of gene expression and stable gene …
In normal cells, it assures the proper regulation of gene expression and stable gene …
[HTML][HTML] DNA methyltransferases: a novel target for prevention and therapy
Cancer is the second leading cause of death in US. Despite the emergence of new, targeted
agents, and the use of various therapeutic combinations, none of the available treatment …
agents, and the use of various therapeutic combinations, none of the available treatment …
[HTML][HTML] Epigenetic mechanisms in memory and cognitive decline associated with aging and Alzheimer's disease
Epigenetic mechanisms, which include DNA methylation, a variety of post-translational
modifications of histone proteins (acetylation, phosphorylation, methylation, ubiquitination …
modifications of histone proteins (acetylation, phosphorylation, methylation, ubiquitination …
Epigenetic control of female puberty
A Lomniczi, A Loche, JM Castellano… - Nature …, 2013 - nature.com
The timing of puberty is controlled by many genes. The elements coordinating this process
have not, however, been identified. Here we show that an epigenetic mechanism of …
have not, however, been identified. Here we show that an epigenetic mechanism of …
RETRACTED: Methylation Mediated Silencing of MicroRNA-1 Gene and Its Role in Hepatocellular Carcinogenesis
J Datta, H Kutay, MW Nasser, GJ Nuovo, B Wang… - Cancer research, 2008 - AACR
MicroRNAs (miR) are a class of small (∼ 21 nucleotide) noncoding RNAs that, in general,
negatively regulate gene expression. Some miRs harboring CGIs undergo methylation …
negatively regulate gene expression. Some miRs harboring CGIs undergo methylation …
[PDF][PDF] Enhancing the cytotoxic effects of PARP inhibitors with DNA demethylating agents–a potential therapy for cancer
NE Muvarak, K Chowdhury, L Xia, C Robert, EY Choi… - Cancer cell, 2016 - cell.com
Poly (ADP-ribose) polymerase inhibitors (PARPis) are clinically effective predominantly for
BRCA-mutant tumors. We introduce a mechanism-based strategy to enhance PARPi efficacy …
BRCA-mutant tumors. We introduce a mechanism-based strategy to enhance PARPi efficacy …
[HTML][HTML] A new class of quinoline-based DNA hypomethylating agents reactivates tumor suppressor genes by blocking DNA methyltransferase 1 activity and inducing …
Reactivation of silenced tumor suppressor genes by 5-azacytidine (Vidaza) and its congener
5-aza-2′-deoxycytidine (decitabine) has provided an alternate approach to cancer therapy …
5-aza-2′-deoxycytidine (decitabine) has provided an alternate approach to cancer therapy …
Anti-aging pharmacology: promises and pitfalls
Life expectancy has grown dramatically in modern times. This increase, however, is not
accompanied by the same increase in healthspan. Efforts to extend healthspan through …
accompanied by the same increase in healthspan. Efforts to extend healthspan through …
Non-coding RNAs, epigenetics, and cancer: tying it all together
HJ Ferreira, M Esteller - Cancer and Metastasis Reviews, 2018 - Springer
While only a small part of the human genome encodes for proteins, biological functions for
the so-called junk genome are increasingly being recognized through high-throughput …
the so-called junk genome are increasingly being recognized through high-throughput …
Plant-derived epigenetic modulators for cancer treatment and prevention
Carcinogenesis is a complex and multistep process that involves the accumulation of
successive transformational events driven by genetic mutations and epigenetic alterations …
successive transformational events driven by genetic mutations and epigenetic alterations …